The NLRP3 inflammasome contributes to inflammation‐induced morphological and metabolic alterations in skeletal muscle
Background Systemic inflammation is associated with skeletal muscle atrophy and metabolic dysfunction. Although the nucleotide‐binding oligomerization domain‐like receptor family pyrin domain containing 3 (NLRP3) inflammasome contributes to cytokine production in immune cells, its role in skeletal m...
Saved in:
| Published in | Journal of cachexia, sarcopenia and muscle Vol. 13; no. 6; pp. 3048 - 3061 |
|---|---|
| Main Authors | , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Germany
John Wiley & Sons, Inc
01.12.2022
John Wiley and Sons Inc Wiley |
| Subjects | |
| Online Access | Get full text |
| ISSN | 2190-5991 2190-6009 2190-6009 |
| DOI | 10.1002/jcsm.13062 |
Cover
| Abstract | Background
Systemic inflammation is associated with skeletal muscle atrophy and metabolic dysfunction. Although the nucleotide‐binding oligomerization domain‐like receptor family pyrin domain containing 3 (NLRP3) inflammasome contributes to cytokine production in immune cells, its role in skeletal muscle is poorly understood. Here, we studied the link between inflammation, NLRP3, muscle morphology, and metabolism in in vitro cultured C2C12 myotubes, independent of immune cell involvement.
Methods
Differentiated C2C12 myotubes were treated with lipopolysaccharide (LPS; 0, 10, and 100–200 ng/mL) to induce activation of the NLRP3 inflammasome with and without MCC950, a pharmacological inhibitor of NLRP3‐induced IL‐1β production. We assessed markers of the NLRP3 inflammasome, cell diameter, reactive oxygen species, and mitochondrial function.
Results
NLRP3 gene expression and protein concentrations increased in a time‐dependent and dose‐dependent manner. Intracellular IL‐1β concentration significantly increased (P < 0.0001), but significantly less with MCC950 (P = 0.03), suggestive of moderate activation of the NLRP3 inflammasome in cultured myotubes upon LPS stimulation. LPS suppressed myotube growth after 24 h (P = 0.03), and myotubes remained smaller up to 72 h (P = 0.0009). Exposure of myotubes to IL‐1β caused similar alterations in cell morphology, and MCC950 mitigated these LPS‐induced differences in cell diameter. NLRP3 appeared to co‐localize with mitochondria, more so upon exposure to LPS. Mitochondrial reactive oxygen species were higher after LPS (P = 0.03), but not after addition of MCC950. Myotubes had higher glycolytic rates, and mitochondria were more fragmented upon LPS exposure, which was not altered by MCC950 supplementation.
Conclusions
LPS‐induced activation of the NLRP3 inflammasome in cultured myotubes contributes to morphological and metabolic alterations, likely due to its mitochondrial association. |
|---|---|
| AbstractList | Background Systemic inflammation is associated with skeletal muscle atrophy and metabolic dysfunction. Although the nucleotide‐binding oligomerization domain‐like receptor family pyrin domain containing 3 (NLRP3) inflammasome contributes to cytokine production in immune cells, its role in skeletal muscle is poorly understood. Here, we studied the link between inflammation, NLRP3, muscle morphology, and metabolism in in vitro cultured C2C12 myotubes, independent of immune cell involvement. Methods Differentiated C2C12 myotubes were treated with lipopolysaccharide (LPS; 0, 10, and 100–200 ng/mL) to induce activation of the NLRP3 inflammasome with and without MCC950, a pharmacological inhibitor of NLRP3‐induced IL‐1β production. We assessed markers of the NLRP3 inflammasome, cell diameter, reactive oxygen species, and mitochondrial function. Results NLRP3 gene expression and protein concentrations increased in a time‐dependent and dose‐dependent manner. Intracellular IL‐1β concentration significantly increased (P < 0.0001), but significantly less with MCC950 (P = 0.03), suggestive of moderate activation of the NLRP3 inflammasome in cultured myotubes upon LPS stimulation. LPS suppressed myotube growth after 24 h (P = 0.03), and myotubes remained smaller up to 72 h (P = 0.0009). Exposure of myotubes to IL‐1β caused similar alterations in cell morphology, and MCC950 mitigated these LPS‐induced differences in cell diameter. NLRP3 appeared to co‐localize with mitochondria, more so upon exposure to LPS. Mitochondrial reactive oxygen species were higher after LPS (P = 0.03), but not after addition of MCC950. Myotubes had higher glycolytic rates, and mitochondria were more fragmented upon LPS exposure, which was not altered by MCC950 supplementation. Conclusions LPS‐induced activation of the NLRP3 inflammasome in cultured myotubes contributes to morphological and metabolic alterations, likely due to its mitochondrial association. Abstract Background Systemic inflammation is associated with skeletal muscle atrophy and metabolic dysfunction. Although the nucleotide‐binding oligomerization domain‐like receptor family pyrin domain containing 3 (NLRP3) inflammasome contributes to cytokine production in immune cells, its role in skeletal muscle is poorly understood. Here, we studied the link between inflammation, NLRP3, muscle morphology, and metabolism in in vitro cultured C2C12 myotubes, independent of immune cell involvement. Methods Differentiated C2C12 myotubes were treated with lipopolysaccharide (LPS; 0, 10, and 100–200 ng/mL) to induce activation of the NLRP3 inflammasome with and without MCC950, a pharmacological inhibitor of NLRP3‐induced IL‐1β production. We assessed markers of the NLRP3 inflammasome, cell diameter, reactive oxygen species, and mitochondrial function. Results NLRP3 gene expression and protein concentrations increased in a time‐dependent and dose‐dependent manner. Intracellular IL‐1β concentration significantly increased (P < 0.0001), but significantly less with MCC950 (P = 0.03), suggestive of moderate activation of the NLRP3 inflammasome in cultured myotubes upon LPS stimulation. LPS suppressed myotube growth after 24 h (P = 0.03), and myotubes remained smaller up to 72 h (P = 0.0009). Exposure of myotubes to IL‐1β caused similar alterations in cell morphology, and MCC950 mitigated these LPS‐induced differences in cell diameter. NLRP3 appeared to co‐localize with mitochondria, more so upon exposure to LPS. Mitochondrial reactive oxygen species were higher after LPS (P = 0.03), but not after addition of MCC950. Myotubes had higher glycolytic rates, and mitochondria were more fragmented upon LPS exposure, which was not altered by MCC950 supplementation. Conclusions LPS‐induced activation of the NLRP3 inflammasome in cultured myotubes contributes to morphological and metabolic alterations, likely due to its mitochondrial association. Systemic inflammation is associated with skeletal muscle atrophy and metabolic dysfunction. Although the nucleotide-binding oligomerization domain-like receptor family pyrin domain containing 3 (NLRP3) inflammasome contributes to cytokine production in immune cells, its role in skeletal muscle is poorly understood. Here, we studied the link between inflammation, NLRP3, muscle morphology, and metabolism in in vitro cultured C2C12 myotubes, independent of immune cell involvement.BACKGROUNDSystemic inflammation is associated with skeletal muscle atrophy and metabolic dysfunction. Although the nucleotide-binding oligomerization domain-like receptor family pyrin domain containing 3 (NLRP3) inflammasome contributes to cytokine production in immune cells, its role in skeletal muscle is poorly understood. Here, we studied the link between inflammation, NLRP3, muscle morphology, and metabolism in in vitro cultured C2C12 myotubes, independent of immune cell involvement.Differentiated C2C12 myotubes were treated with lipopolysaccharide (LPS; 0, 10, and 100-200 ng/mL) to induce activation of the NLRP3 inflammasome with and without MCC950, a pharmacological inhibitor of NLRP3-induced IL-1β production. We assessed markers of the NLRP3 inflammasome, cell diameter, reactive oxygen species, and mitochondrial function.METHODSDifferentiated C2C12 myotubes were treated with lipopolysaccharide (LPS; 0, 10, and 100-200 ng/mL) to induce activation of the NLRP3 inflammasome with and without MCC950, a pharmacological inhibitor of NLRP3-induced IL-1β production. We assessed markers of the NLRP3 inflammasome, cell diameter, reactive oxygen species, and mitochondrial function.NLRP3 gene expression and protein concentrations increased in a time-dependent and dose-dependent manner. Intracellular IL-1β concentration significantly increased (P < 0.0001), but significantly less with MCC950 (P = 0.03), suggestive of moderate activation of the NLRP3 inflammasome in cultured myotubes upon LPS stimulation. LPS suppressed myotube growth after 24 h (P = 0.03), and myotubes remained smaller up to 72 h (P = 0.0009). Exposure of myotubes to IL-1β caused similar alterations in cell morphology, and MCC950 mitigated these LPS-induced differences in cell diameter. NLRP3 appeared to co-localize with mitochondria, more so upon exposure to LPS. Mitochondrial reactive oxygen species were higher after LPS (P = 0.03), but not after addition of MCC950. Myotubes had higher glycolytic rates, and mitochondria were more fragmented upon LPS exposure, which was not altered by MCC950 supplementation.RESULTSNLRP3 gene expression and protein concentrations increased in a time-dependent and dose-dependent manner. Intracellular IL-1β concentration significantly increased (P < 0.0001), but significantly less with MCC950 (P = 0.03), suggestive of moderate activation of the NLRP3 inflammasome in cultured myotubes upon LPS stimulation. LPS suppressed myotube growth after 24 h (P = 0.03), and myotubes remained smaller up to 72 h (P = 0.0009). Exposure of myotubes to IL-1β caused similar alterations in cell morphology, and MCC950 mitigated these LPS-induced differences in cell diameter. NLRP3 appeared to co-localize with mitochondria, more so upon exposure to LPS. Mitochondrial reactive oxygen species were higher after LPS (P = 0.03), but not after addition of MCC950. Myotubes had higher glycolytic rates, and mitochondria were more fragmented upon LPS exposure, which was not altered by MCC950 supplementation.LPS-induced activation of the NLRP3 inflammasome in cultured myotubes contributes to morphological and metabolic alterations, likely due to its mitochondrial association.CONCLUSIONSLPS-induced activation of the NLRP3 inflammasome in cultured myotubes contributes to morphological and metabolic alterations, likely due to its mitochondrial association. Background Systemic inflammation is associated with skeletal muscle atrophy and metabolic dysfunction. Although the nucleotide‐binding oligomerization domain‐like receptor family pyrin domain containing 3 (NLRP3) inflammasome contributes to cytokine production in immune cells, its role in skeletal muscle is poorly understood. Here, we studied the link between inflammation, NLRP3, muscle morphology, and metabolism in in vitro cultured C2C12 myotubes, independent of immune cell involvement. Methods Differentiated C2C12 myotubes were treated with lipopolysaccharide (LPS; 0, 10, and 100–200 ng/mL) to induce activation of the NLRP3 inflammasome with and without MCC950, a pharmacological inhibitor of NLRP3‐induced IL‐1β production. We assessed markers of the NLRP3 inflammasome, cell diameter, reactive oxygen species, and mitochondrial function. Results NLRP3 gene expression and protein concentrations increased in a time‐dependent and dose‐dependent manner. Intracellular IL‐1β concentration significantly increased (P < 0.0001), but significantly less with MCC950 (P = 0.03), suggestive of moderate activation of the NLRP3 inflammasome in cultured myotubes upon LPS stimulation. LPS suppressed myotube growth after 24 h (P = 0.03), and myotubes remained smaller up to 72 h (P = 0.0009). Exposure of myotubes to IL‐1β caused similar alterations in cell morphology, and MCC950 mitigated these LPS‐induced differences in cell diameter. NLRP3 appeared to co‐localize with mitochondria, more so upon exposure to LPS. Mitochondrial reactive oxygen species were higher after LPS (P = 0.03), but not after addition of MCC950. Myotubes had higher glycolytic rates, and mitochondria were more fragmented upon LPS exposure, which was not altered by MCC950 supplementation. Conclusions LPS‐induced activation of the NLRP3 inflammasome in cultured myotubes contributes to morphological and metabolic alterations, likely due to its mitochondrial association. Systemic inflammation is associated with skeletal muscle atrophy and metabolic dysfunction. Although the nucleotide-binding oligomerization domain-like receptor family pyrin domain containing 3 (NLRP3) inflammasome contributes to cytokine production in immune cells, its role in skeletal muscle is poorly understood. Here, we studied the link between inflammation, NLRP3, muscle morphology, and metabolism in in vitro cultured C2C12 myotubes, independent of immune cell involvement. Differentiated C2C12 myotubes were treated with lipopolysaccharide (LPS; 0, 10, and 100-200 ng/mL) to induce activation of the NLRP3 inflammasome with and without MCC950, a pharmacological inhibitor of NLRP3-induced IL-1β production. We assessed markers of the NLRP3 inflammasome, cell diameter, reactive oxygen species, and mitochondrial function. NLRP3 gene expression and protein concentrations increased in a time-dependent and dose-dependent manner. Intracellular IL-1β concentration significantly increased (P < 0.0001), but significantly less with MCC950 (P = 0.03), suggestive of moderate activation of the NLRP3 inflammasome in cultured myotubes upon LPS stimulation. LPS suppressed myotube growth after 24 h (P = 0.03), and myotubes remained smaller up to 72 h (P = 0.0009). Exposure of myotubes to IL-1β caused similar alterations in cell morphology, and MCC950 mitigated these LPS-induced differences in cell diameter. NLRP3 appeared to co-localize with mitochondria, more so upon exposure to LPS. Mitochondrial reactive oxygen species were higher after LPS (P = 0.03), but not after addition of MCC950. Myotubes had higher glycolytic rates, and mitochondria were more fragmented upon LPS exposure, which was not altered by MCC950 supplementation. LPS-induced activation of the NLRP3 inflammasome in cultured myotubes contributes to morphological and metabolic alterations, likely due to its mitochondrial association. |
| Author | Vázquez‐Cruz, Mariana Soares, Madu N. Wüst, Rob C.I. Shi, Andi Wit, Gerard M. J. Broeksma, Bonnie C. Everts, Bart Eggelbusch, Moritz Jaspers, Richard T. |
| AuthorAffiliation | 5 Department of Prosthodontics Affiliated Stomatology Hospital of Guangzhou Medical University, Guangdong Engineering Research Center of Oral Restoration and Reconstruction, Guangzhou Key Laboratory of Basic and Applied Research of Oral Regenerative Medicine Guangzhou China 3 Faculty of Sports and Nutrition, Center of Expertise Urban Vitality Amsterdam University of Applied Sciences Amsterdam The Netherlands 6 Department of Parasitology, Leiden University Medical Center University of Leiden Leiden The Netherlands 2 Department of Nutrition and Dietetics, Amsterdam UMC location VUmc Vrije Universiteit Amsterdam, Amsterdam Movement Sciences Amsterdam The Netherlands 4 Department of Oral and Maxillofacial Surgery/Pathology, Amsterdam UMC and Academic Center for Dentistry Amsterdam Vrije Universiteit Amsterdam, Amsterdam Movement Sciences Amsterdam The Netherlands 1 Laboratory for Myology, Department of Human Movement Sciences, Faculty of Behavioural and Movement Sciences Vrije Universiteit Amst |
| AuthorAffiliation_xml | – name: 6 Department of Parasitology, Leiden University Medical Center University of Leiden Leiden The Netherlands – name: 5 Department of Prosthodontics Affiliated Stomatology Hospital of Guangzhou Medical University, Guangdong Engineering Research Center of Oral Restoration and Reconstruction, Guangzhou Key Laboratory of Basic and Applied Research of Oral Regenerative Medicine Guangzhou China – name: 1 Laboratory for Myology, Department of Human Movement Sciences, Faculty of Behavioural and Movement Sciences Vrije Universiteit Amsterdam, Amsterdam Movement Sciences Amsterdam The Netherlands – name: 3 Faculty of Sports and Nutrition, Center of Expertise Urban Vitality Amsterdam University of Applied Sciences Amsterdam The Netherlands – name: 2 Department of Nutrition and Dietetics, Amsterdam UMC location VUmc Vrije Universiteit Amsterdam, Amsterdam Movement Sciences Amsterdam The Netherlands – name: 4 Department of Oral and Maxillofacial Surgery/Pathology, Amsterdam UMC and Academic Center for Dentistry Amsterdam Vrije Universiteit Amsterdam, Amsterdam Movement Sciences Amsterdam The Netherlands |
| Author_xml | – sequence: 1 givenname: Moritz orcidid: 0000-0002-4006-4063 surname: Eggelbusch fullname: Eggelbusch, Moritz organization: Amsterdam University of Applied Sciences – sequence: 2 givenname: Andi surname: Shi fullname: Shi, Andi organization: Affiliated Stomatology Hospital of Guangzhou Medical University, Guangdong Engineering Research Center of Oral Restoration and Reconstruction, Guangzhou Key Laboratory of Basic and Applied Research of Oral Regenerative Medicine – sequence: 3 givenname: Bonnie C. surname: Broeksma fullname: Broeksma, Bonnie C. organization: Vrije Universiteit Amsterdam, Amsterdam Movement Sciences – sequence: 4 givenname: Mariana surname: Vázquez‐Cruz fullname: Vázquez‐Cruz, Mariana organization: Vrije Universiteit Amsterdam, Amsterdam Movement Sciences – sequence: 5 givenname: Madu N. surname: Soares fullname: Soares, Madu N. organization: Vrije Universiteit Amsterdam, Amsterdam Movement Sciences – sequence: 6 givenname: Gerard M. J. surname: Wit fullname: Wit, Gerard M. J. organization: Vrije Universiteit Amsterdam, Amsterdam Movement Sciences – sequence: 7 givenname: Bart orcidid: 0000-0002-3764-5131 surname: Everts fullname: Everts, Bart organization: University of Leiden – sequence: 8 givenname: Richard T. orcidid: 0000-0002-6951-0952 surname: Jaspers fullname: Jaspers, Richard T. organization: Affiliated Stomatology Hospital of Guangzhou Medical University, Guangdong Engineering Research Center of Oral Restoration and Reconstruction, Guangzhou Key Laboratory of Basic and Applied Research of Oral Regenerative Medicine – sequence: 9 givenname: Rob C.I. orcidid: 0000-0003-3781-5177 surname: Wüst fullname: Wüst, Rob C.I. email: r.wust@vu.nl organization: Vrije Universiteit Amsterdam, Amsterdam Movement Sciences |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35978267$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kttu1DAQhiNUREvpDQ-AInGDkLb4EDvxDRJacShaDoJybdnOeNeLEy92QtU7HoFn5EnwbpYVrRC-sTXz_b_HnrlfHPWhh6J4iNE5Rog8W5vUnWOKOLlTnBAs0IwjJI72ZyYEPi7OUlqjvCqOOUP3imPKRN0QXp8UV5crKN8vPn2kpeutV12nUuigNKEfotPjAKkcwiE3uND_-vHT9e1ooC27EDer4MPSGeVL1ecIDEoH70yp_ABxJ0hZXqav4HPOl92YjIcHxV2rfIKz_X5afHn18nL-Zrb48Ppi_mIxM4w2ZGZZjVrR6LbRgoiKIeCEVxVqtWGYEmYp5KAl3Nq6QtgQ1tbKGgRNw2uiLD0tLibfNqi13ETXqXgtg3JyFwhxKVUcXK5Iaqy1UMBrVOGKN0pzWiPUtkIbqqltstfzyWsz6g5aA_mLlL9hejPTu5Vchu9S1BWrOM8GT_YGMXwbIQ2yc8mA96qHMCZJakRFwynf3vX4FroOY-zzV2WK0Urk7olMPfq7okMpf_qbgacTYGJIKYI9IBjJ7fzI7fzI3fxkGN2CjRt2Hcyvcf7fEjxJrpyH6_-Yy7fzz-8mzW87F9pN |
| CitedBy_id | crossref_primary_10_1007_s12035_024_04590_x crossref_primary_10_1007_s00011_023_01831_y crossref_primary_10_3390_nu15132832 crossref_primary_10_1007_s11154_025_09954_9 crossref_primary_10_1093_cvr_cvaf004 crossref_primary_10_3389_fcell_2023_1212779 crossref_primary_10_3389_fsurg_2022_1056732 crossref_primary_10_3389_fonc_2024_1338325 crossref_primary_10_1016_j_abb_2024_110215 crossref_primary_10_1016_j_rvsc_2025_105612 crossref_primary_10_3390_ijms24021403 crossref_primary_10_3390_livers4040045 crossref_primary_10_3390_molecules29030712 crossref_primary_10_1002_ctm2_1528 crossref_primary_10_47447_tjsm_0872 crossref_primary_10_1016_j_biopha_2023_115147 crossref_primary_10_3390_ijms25031439 crossref_primary_10_1016_j_lfs_2023_121948 crossref_primary_10_1113_JP286216 crossref_primary_10_1097_SHK_0000000000002430 crossref_primary_10_3390_ijms24055040 crossref_primary_10_1038_s42003_025_07654_3 crossref_primary_10_1111_apha_14145 crossref_primary_10_1002_fsn3_4550 crossref_primary_10_1002_jcsm_13294 crossref_primary_10_1016_j_bj_2023_100636 crossref_primary_10_1210_endrev_bnad004 crossref_primary_10_1002_ctd2_70019 crossref_primary_10_1007_s10787_024_01454_7 crossref_primary_10_3390_biology12030431 crossref_primary_10_1016_j_molimm_2023_09_007 |
| Cites_doi | 10.3390/ijms22084100 10.1002/jcsm.12899 10.1074/jbc.M114.550624 10.1038/nature09663 10.3389/fphys.2014.00503 10.1007/s00253-020-10614-y 10.1161/CIRCRESAHA.119.316364 10.4049/jimmunol.0901363 10.1038/srep15489 10.1016/j.bbadis.2013.11.001 10.1038/nm.3806 10.1038/nature07201 10.1073/pnas.2002250117 10.1002/ar.23834 10.1093/infdis/161.1.79 10.1111/acel.12102 10.1152/ajpcell.00387.2010 10.1016/S0140-6736(98)09286-1 10.18632/oncotarget.8243 10.1016/j.cell.2013.02.054 10.1186/s40635-016-0115-0 10.1113/expphysiol.2012.068338 10.1038/nrd4467 10.1111/j.1600-065X.2011.01046.x 10.3390/antiox10040588 10.1002/jcsm.12761 10.1002/jcsm.12129 10.2353/ajpath.2010.090058 10.1002/jcp.25388 10.2337/db06-1491 10.1016/j.bbrc.2021.02.007 10.1152/ajpcell.00626.2008 10.1016/0741-5214(93)90118-6 10.1002/jcsm.12238 10.1186/s12915-018-0501-z 10.1016/j.canlet.2018.01.034 10.1152/ajpendo.00060.2017 10.1002/jcsm.12896 10.1016/j.bbagen.2013.08.014 |
| ContentType | Journal Article |
| Copyright | 2022 The Authors. Journal of Cachexia, Sarcopenia and Muscle published by John Wiley & Sons Ltd on behalf of Society on Sarcopenia, Cachexia and Wasting Disorders. 2022. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the "License"). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| Copyright_xml | – notice: 2022 The Authors. Journal of Cachexia, Sarcopenia and Muscle published by John Wiley & Sons Ltd on behalf of Society on Sarcopenia, Cachexia and Wasting Disorders. – notice: 2022. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the "License"). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| DBID | 24P AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S PHGZM PHGZT PIMPY PKEHL PQEST PQQKQ PQUKI 7X8 5PM DOA |
| DOI | 10.1002/jcsm.13062 |
| DatabaseName | Wiley Online Library Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Open Access Full Text |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete Health Research Premium Collection ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest Central (New) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | Publicly Available Content Database MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: 24P name: Wiley Online Library Open Access url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html sourceTypes: Publisher – sequence: 3 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 5 dbid: 7X7 name: Health & Medical Collection (Proquest) url: https://search.proquest.com/healthcomplete sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| DocumentTitleAlternate | The NLRP3 inflammasome in skeletal muscle |
| EISSN | 2190-6009 |
| EndPage | 3061 |
| ExternalDocumentID | oai_doaj_org_article_b1bb9ae67041468ab63700dd9bc3b3f8 PMC9745466 35978267 10_1002_jcsm_13062 JCSM13062 |
| Genre | article Journal Article |
| GeographicLocations | Minneapolis Minnesota United States--US Germany |
| GeographicLocations_xml | – name: Minneapolis Minnesota – name: United States--US – name: Germany |
| GroupedDBID | --- 0R~ 1OC 24P 2VQ 4.4 40G 53G 5VS 7X7 8FI 8FJ AAFWJ AAKDD AAMMB AAZKR ABUWG ACCMX ACXQS ADBBV ADKYN ADRAZ ADZMN AEFGJ AENEX AFKRA AFPKN AGXDD AHBYD AHSBF AIDQK AIDYY ALMA_UNASSIGNED_HOLDINGS ALUQN AMKLP AOIJS AVUZU AZFZN BAWUL BCNDV BENPR BPHCQ BVXVI CCPQU DIK EBS EJD EMOBN FYUFA GROUPED_DOAJ GX1 H13 HMCUK HYE IAO IHR INH ITC KQ8 M48 O9- OK1 PHGZM PHGZT PIMPY PQQKQ PROAC PUEGO RPM RSV SMD SOJ U2A UKHRP WIN ZOVNA AAYXX CITATION AAHHS ACCFJ ADINQ ADPDF ADZOD AEEZP AEQDE AIWBW AJBDE ALIPV CGR CUY CVF ECM EIF M~E NPM OVD OVEED 3V. 7XB 8FK AZQEC DWQXO K9. PKEHL PQEST PQUKI 7X8 5PM |
| ID | FETCH-LOGICAL-c5382-f570d98bd8b929450e626440dbc51325f3e450f26ff7401c25d7afc0e88672af3 |
| IEDL.DBID | DOA |
| ISSN | 2190-5991 2190-6009 |
| IngestDate | Wed Aug 27 01:30:55 EDT 2025 Tue Sep 30 17:17:45 EDT 2025 Thu Sep 04 16:06:11 EDT 2025 Sat Aug 23 14:56:32 EDT 2025 Wed Feb 19 02:26:04 EST 2025 Wed Oct 01 05:40:03 EDT 2025 Thu Apr 24 23:01:35 EDT 2025 Sun Sep 21 06:16:37 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 6 |
| Keywords | Metabolism NLRP3 inflammasome Morphology Skeletal muscle Systemic inflammation |
| Language | English |
| License | Attribution-NonCommercial 2022 The Authors. Journal of Cachexia, Sarcopenia and Muscle published by John Wiley & Sons Ltd on behalf of Society on Sarcopenia, Cachexia and Wasting Disorders. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c5382-f570d98bd8b929450e626440dbc51325f3e450f26ff7401c25d7afc0e88672af3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| ORCID | 0000-0002-6951-0952 0000-0002-4006-4063 0000-0002-3764-5131 0000-0003-3781-5177 |
| OpenAccessLink | https://doaj.org/article/b1bb9ae67041468ab63700dd9bc3b3f8 |
| PMID | 35978267 |
| PQID | 2753492679 |
| PQPubID | 4370305 |
| PageCount | 14 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_b1bb9ae67041468ab63700dd9bc3b3f8 pubmedcentral_primary_oai_pubmedcentral_nih_gov_9745466 proquest_miscellaneous_2703986368 proquest_journals_2753492679 pubmed_primary_35978267 crossref_primary_10_1002_jcsm_13062 crossref_citationtrail_10_1002_jcsm_13062 wiley_primary_10_1002_jcsm_13062_JCSM13062 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | December 2022 |
| PublicationDateYYYYMMDD | 2022-12-01 |
| PublicationDate_xml | – month: 12 year: 2022 text: December 2022 |
| PublicationDecade | 2020 |
| PublicationPlace | Germany |
| PublicationPlace_xml | – name: Germany – name: Heidelberg – name: Hoboken |
| PublicationTitle | Journal of cachexia, sarcopenia and muscle |
| PublicationTitleAlternate | J Cachexia Sarcopenia Muscle |
| PublicationYear | 2022 |
| Publisher | John Wiley & Sons, Inc John Wiley and Sons Inc Wiley |
| Publisher_xml | – name: John Wiley & Sons, Inc – name: John Wiley and Sons Inc – name: Wiley |
| References | 2017; 5 2021; 27 2015; 14 2017; 8 2015; 5 2021; 22 2018; 301 2021; 547 2009; 297 2020; 104 2020; 127 2014; 1842 2007; 56 2014; 1840 2017; 313 1990; 161 2018; 9 2011; 301 2016; 7 2014; 5 2021; 10 2021; 12 1993; 17 2011; 469 2013; 98 2013; 12 2015; 21 2010; 176 2022; 13 2020; 117 2016; 231 2009; 183 2007; 2 1999; 353 2008; 454 2018; 419 2013; 153 2018; 16 2011; 243 2014; 289 e_1_2_8_28_1 Wüst RCI (e_1_2_8_7_1) 2007; 2 e_1_2_8_29_1 e_1_2_8_24_1 e_1_2_8_25_1 e_1_2_8_26_1 e_1_2_8_27_1 e_1_2_8_3_1 e_1_2_8_5_1 e_1_2_8_4_1 e_1_2_8_6_1 e_1_2_8_9_1 e_1_2_8_8_1 e_1_2_8_20_1 e_1_2_8_21_1 e_1_2_8_42_1 e_1_2_8_22_1 e_1_2_8_23_1 e_1_2_8_41_1 e_1_2_8_40_1 e_1_2_8_17_1 e_1_2_8_18_1 e_1_2_8_39_1 e_1_2_8_19_1 Brito Valente AF (e_1_2_8_2_1) 2021; 27 e_1_2_8_13_1 e_1_2_8_36_1 e_1_2_8_14_1 e_1_2_8_35_1 e_1_2_8_15_1 e_1_2_8_38_1 e_1_2_8_16_1 e_1_2_8_37_1 e_1_2_8_32_1 e_1_2_8_10_1 e_1_2_8_31_1 e_1_2_8_11_1 e_1_2_8_34_1 e_1_2_8_12_1 e_1_2_8_33_1 e_1_2_8_30_1 |
| References_xml | – volume: 231 start-page: 2517 year: 2016 end-page: 2528 article-title: Effects of 1,25(OH)2 D3 and 25(OH)D3 on C2C12 myoblast proliferation, differentiation, and myotube hypertrophy publication-title: J Cell Physiol – volume: 297 start-page: C706 year: 2009 end-page: C714 article-title: Interleukin‐1 stimulates catabolism in C2C12 myotubes publication-title: Am J Physiol Cell Physiol – volume: 419 start-page: 8 year: 2018 end-page: 19 article-title: The NLRP3 inflammasome: Role in metabolic disorders and regulation by metabolic pathways publication-title: Cancer Lett – volume: 127 start-page: 73 year: 2020 end-page: 90 article-title: Inflammasomes and proteostasis novel molecular mechanisms associated with atrial fibrillation publication-title: Circ Res – volume: 16 start-page: 33 year: 2018 article-title: Downregulation of the NLRP3 inflammasome by adiponectin rescues Duchenne muscular dystrophy publication-title: BMC Biol – volume: 12 start-page: 763 year: 2013 end-page: 771 article-title: Mitochondrial‐targeted peptide rapidly improves mitochondrial energetics and skeletal muscle performance in aged mice publication-title: Aging Cell – volume: 183 start-page: 787 year: 2009 end-page: 791 article-title: Cutting edge: NF‐kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression publication-title: J Immunol – volume: 469 start-page: 221 year: 2011 end-page: 225 article-title: A role for mitochondria in NLRP3 inflammasome activation publication-title: Nature – volume: 13 start-page: 11 year: 2022 end-page: 22 article-title: Skeletal muscle alterations in patients with acute Covid‐19 and post‐acute sequelae of Covid‐19 publication-title: J Cachexia Sarcopenia Muscle – volume: 5 start-page: 3 year: 2017 article-title: Deletion of Nlrp3 protects from inflammation‐induced skeletal muscle atrophy publication-title: Intensive Care Med Exp – volume: 117 start-page: 15363 year: 2020 end-page: 15373 article-title: Mitochondrial protein interaction landscape of SS‐31 publication-title: Proc Natl Acad Sci U S A – volume: 27 start-page: 42 year: 2021 end-page: 53 article-title: Regular physical exercise mediates the immune response in atherosclerosis publication-title: Exerc Immunol Rev – volume: 21 start-page: 248 year: 2015 end-page: 255 article-title: A small‐molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases publication-title: Nat Med – volume: 301 start-page: 1551 year: 2018 end-page: 1563 article-title: Immunological behavior analysis of muscle cells under IFN‐gamma stimulation in vitro and in vivo publication-title: Anat Rec (Hoboken) – volume: 56 start-page: 1761 year: 2007 end-page: 1772 article-title: Metabolic endotoxemia initiates obesity and insulin resistance publication-title: Diabetes – volume: 12 start-page: 1466 year: 2021 end-page: 1476 article-title: Association of systemic inflammation with survival in patients with cancer cachexia: results from a multicentre cohort study publication-title: J Cachexia Sarcopenia Muscle – volume: 547 start-page: 176 year: 2021 end-page: 182 article-title: Synergistic short‐term and long‐term effects of TGF‐beta1 and 3 on collagen production in differentiating myoblasts publication-title: Biochem Biophys Res Commun – volume: 2 start-page: 289 year: 2007 end-page: 300 article-title: Factors contributing to muscle wasting and dysfunction in COPD patients publication-title: Int J Chron Obstruct Pulmon Dis – volume: 17 start-page: 734 year: 1993 end-page: 737 article-title: Intestinal permeability is increased after major vascular surgery publication-title: J Vasc Surg – volume: 7 start-page: 17479 year: 2016 end-page: 17491 article-title: Mitochondrial reactive oxygen species‐mediated NLRP3 inflammasome activation contributes to aldosterone‐induced renal tubular cells injury publication-title: Oncotarget – volume: 5 start-page: 15489 year: 2015 article-title: Defective mitochondrial fission augments NLRP3 inflammasome activation publication-title: Sci Rep – volume: 153 start-page: 348 year: 2013 end-page: 361 article-title: The adaptor MAVS promotes NLRP3 mitochondrial localization and inflammasome activation publication-title: Cell – volume: 12 start-page: 2259 year: 2021 end-page: 2261 article-title: Ethical guidelines for publishing in the Journal of Cachexia, Sarcopenia and Muscle: Update 2021 publication-title: J Cachexia Sarcopenia Muscle – volume: 5 start-page: 503 year: 2014 article-title: Mitochondria dysfunction in lung cancer‐induced muscle wasting in C2C12 myotubes publication-title: Front Physiol – volume: 98 start-page: 462 year: 2013 end-page: 472 article-title: The Nlrp3 inflammasome promotes myocardial dysfunction in structural cardiomyopathy through interleukin‐1beta publication-title: Exp Physiol – volume: 301 start-page: C895 year: 2011 end-page: C902 article-title: Endotoxin transiently inhibits protein synthesis through Akt and MAPK mediating pathways in C2C12 myotubes publication-title: Am J Physiol Cell Physiol – volume: 176 start-page: 2891 year: 2010 end-page: 2900 article-title: Inflammasome up‐regulation and activation in dysferlin‐deficient skeletal muscle publication-title: Am J Pathol – volume: 10 start-page: 588 year: 2021 article-title: Mitochondrial dysfunction is a common denominator linking skeletal muscle wasting due to disease, aging, and prolonged inactivity publication-title: Antioxidants (Basel) – volume: 9 start-page: 3 year: 2018 end-page: 19 article-title: Skeletal muscle performance and ageing publication-title: J Cachexia Sarcopenia Muscle – volume: 1842 start-page: 175 year: 2014 end-page: 185 article-title: Classical NF‐kappaB activation impairs skeletal muscle oxidative phenotype by reducing IKK‐alpha expression publication-title: Biochim Biophys Acta – volume: 243 start-page: 136 year: 2011 end-page: 151 article-title: The inflammasome: an integrated view publication-title: Immunol Rev – volume: 289 start-page: 19571 year: 2014 end-page: 19584 article-title: Mitochondrial NLRP3 protein induces reactive oxygen species to promote Smad protein signaling and fibrosis independent from the inflammasome publication-title: J Biol Chem – volume: 14 start-page: 58 year: 2015 end-page: 74 article-title: Muscle wasting in disease: Molecular mechanisms and promising therapies publication-title: Nat Rev Drug Discov – volume: 161 start-page: 79 year: 1990 end-page: 84 article-title: Circulating interleukin‐1 and tumor necrosis factor in septic shock and experimental endotoxin fever publication-title: J Infect Dis – volume: 8 start-page: 131 year: 2017 end-page: 144 article-title: Toll‐like receptor 4 signalling mediates inflammation in skeletal muscle of patients with chronic kidney disease publication-title: J Cachexia Sarcopenia Muscle – volume: 313 start-page: E222 year: 2017 end-page: E232 article-title: The NLRP3 inflammasome contributes to sarcopenia and lower muscle glycolytic potential in old mice publication-title: Am J Physiol Endocrinol Metab – volume: 22 year: 2021 article-title: The antibiotic doxycycline impairs cardiac mitochondrial and contractile function publication-title: Int J Mol Sci – volume: 1840 start-page: 1433 year: 2014 end-page: 1440 article-title: Ambiguities in NLRP3 inflammasome regulation: Is there a role for mitochondria? publication-title: Biochim Biophys Acta – volume: 454 start-page: 428 year: 2008 end-page: 435 article-title: Origin and physiological roles of inflammation publication-title: Nature – volume: 353 start-page: 1838 year: 1999 end-page: 1842 article-title: Endotoxin and immune activation in chronic heart failure: A prospective cohort study publication-title: Lancet – volume: 104 start-page: 6129 year: 2020 end-page: 6140 article-title: Crosstalk between ER stress, NLRP3 inflammasome, and inflammation publication-title: Appl Microbiol Biotechnol – ident: e_1_2_8_22_1 doi: 10.3390/ijms22084100 – ident: e_1_2_8_42_1 doi: 10.1002/jcsm.12899 – ident: e_1_2_8_15_1 doi: 10.1074/jbc.M114.550624 – ident: e_1_2_8_37_1 doi: 10.1038/nature09663 – volume: 2 start-page: 289 year: 2007 ident: e_1_2_8_7_1 article-title: Factors contributing to muscle wasting and dysfunction in COPD patients publication-title: Int J Chron Obstruct Pulmon Dis – ident: e_1_2_8_26_1 doi: 10.3389/fphys.2014.00503 – ident: e_1_2_8_35_1 doi: 10.1007/s00253-020-10614-y – ident: e_1_2_8_41_1 doi: 10.1161/CIRCRESAHA.119.316364 – ident: e_1_2_8_23_1 doi: 10.4049/jimmunol.0901363 – ident: e_1_2_8_36_1 doi: 10.1038/srep15489 – ident: e_1_2_8_8_1 doi: 10.1016/j.bbadis.2013.11.001 – ident: e_1_2_8_21_1 doi: 10.1038/nm.3806 – ident: e_1_2_8_9_1 doi: 10.1038/nature07201 – ident: e_1_2_8_39_1 doi: 10.1073/pnas.2002250117 – ident: e_1_2_8_12_1 doi: 10.1002/ar.23834 – ident: e_1_2_8_33_1 doi: 10.1093/infdis/161.1.79 – ident: e_1_2_8_40_1 doi: 10.1111/acel.12102 – ident: e_1_2_8_20_1 doi: 10.1152/ajpcell.00387.2010 – ident: e_1_2_8_17_1 doi: 10.1016/S0140-6736(98)09286-1 – ident: e_1_2_8_27_1 doi: 10.18632/oncotarget.8243 – ident: e_1_2_8_14_1 doi: 10.1016/j.cell.2013.02.054 – ident: e_1_2_8_30_1 doi: 10.1186/s40635-016-0115-0 – ident: e_1_2_8_28_1 doi: 10.1113/expphysiol.2012.068338 – ident: e_1_2_8_18_1 doi: 10.1038/nrd4467 – ident: e_1_2_8_10_1 doi: 10.1111/j.1600-065X.2011.01046.x – ident: e_1_2_8_38_1 doi: 10.3390/antiox10040588 – ident: e_1_2_8_5_1 doi: 10.1002/jcsm.12761 – ident: e_1_2_8_19_1 doi: 10.1002/jcsm.12129 – ident: e_1_2_8_29_1 doi: 10.2353/ajpath.2010.090058 – ident: e_1_2_8_24_1 doi: 10.1002/jcp.25388 – ident: e_1_2_8_3_1 doi: 10.2337/db06-1491 – volume: 27 start-page: 42 year: 2021 ident: e_1_2_8_2_1 article-title: Regular physical exercise mediates the immune response in atherosclerosis publication-title: Exerc Immunol Rev – ident: e_1_2_8_25_1 doi: 10.1016/j.bbrc.2021.02.007 – ident: e_1_2_8_34_1 doi: 10.1152/ajpcell.00626.2008 – ident: e_1_2_8_16_1 doi: 10.1016/0741-5214(93)90118-6 – ident: e_1_2_8_6_1 doi: 10.1002/jcsm.12238 – ident: e_1_2_8_32_1 doi: 10.1186/s12915-018-0501-z – ident: e_1_2_8_11_1 doi: 10.1016/j.canlet.2018.01.034 – ident: e_1_2_8_31_1 doi: 10.1152/ajpendo.00060.2017 – ident: e_1_2_8_4_1 doi: 10.1002/jcsm.12896 – ident: e_1_2_8_13_1 doi: 10.1016/j.bbagen.2013.08.014 |
| SSID | ssj0000461650 |
| Score | 2.4463916 |
| Snippet | Background
Systemic inflammation is associated with skeletal muscle atrophy and metabolic dysfunction. Although the nucleotide‐binding oligomerization... Systemic inflammation is associated with skeletal muscle atrophy and metabolic dysfunction. Although the nucleotide-binding oligomerization domain-like... Background Systemic inflammation is associated with skeletal muscle atrophy and metabolic dysfunction. Although the nucleotide‐binding oligomerization... Abstract Background Systemic inflammation is associated with skeletal muscle atrophy and metabolic dysfunction. Although the nucleotide‐binding oligomerization... |
| SourceID | doaj pubmedcentral proquest pubmed crossref wiley |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 3048 |
| SubjectTerms | Cell culture Chemokines Cytokines Enzymes Furans - pharmacology Gene expression Humans Indenes Inflammasomes - metabolism Inflammation Kinases Laboratories Lipopolysaccharides - pharmacology Metabolism Mitochondria Morphology Muscle, Skeletal - metabolism Musculoskeletal system NLR Family, Pyrin Domain-Containing 3 Protein - genetics NLR Family, Pyrin Domain-Containing 3 Protein - metabolism NLRP3 inflammasome Original Polyclonal antibodies Polymerase chain reaction Proteins Reactive oxygen species Reactive Oxygen Species - metabolism Respiration Skeletal muscle Sulfonamides - pharmacology Systemic inflammation |
| SummonAdditionalLinks | – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NbtQwELagSIhLVf4DLTKCC0hREzu2kxOiFVVV0QoBlfYW-bcUmqRtdtUrj8Az8iTMONnAiqq3yHYixzMef2OPvyHkdWkKFzzLU8ONTwuTuVRznaeyrAwsx9YLG6MtjuT-cXEwE7Nxw60fwyqXNjEaatdZ3CPfZoCrkdxOVe_OL1LMGoWnq2MKjdvkTg5QBbVazdS0x4Jk4jImaWV4Y1oAFpoYStn2d9s3mAxZspU1KVL3X4c3_w-b_BfOxvVob4Osj0CSvh8kf5_c8u0DcvdwPCp_SK5AAejRx8-fOAUlArk3uu8aT2NsOia58j2dd1Mdyuf3z1_goYOsHW06GP-lXaS6hRI_B305O7U0HrAPG33wOu1_wMoFEJ42ix568ogc7334urufjlkWUgvGjqVBqMxVpXGlgREsROYlgqTMGSvAVRWBeygMTIaA2fssE07pYDNfllIxHfhjstZ2rX9KKHpHYK9sESoLQMFUuQH0KHQFlsyZ4BPyZjnOtR0pyDETxlk9kCezGmVSR5kk5NXU9nwg3ri21Q6Ka2qBZNmxoLs8qce5V5vcmEp7qbICL5ppI7nKMucqY7nhoUzI5lLY9TiD-_qvviXk5VQNcw8PVHTruwW2yXhVSi7hE08G3Zh6wsFTA9dNJUStaM1KV1dr2tNvkd8bXDxRSJmQt1G_bvj9-mD3y2F8enbzPzwn9xje24hxOJtkbX658FuApubmRZwyfwBwxSCr priority: 102 providerName: ProQuest – databaseName: Scholars Portal Journals: Open Access dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELaqIiEuiDeBgozgAlIgsWMnOSAEFVVVsRUCVuot8rMUNglsdgXc-An8Rn4JM85DXbHixC2yncj2jGe-ie1vCHlU6Mx6x9JYc-3iTCc2VlylsSxKDe7YOGHCaYtjeTjPjk7EyQ4Z83cOE9htDe0wn9R8uXj6_euPF7Dgnw8Eos8-ma7GrMZoii-AR2Ko3bMB5geLnMlUhmStDG9OC8BEE1Pp-dc3fFOg8N-GO_8-Pnke1ga_dHCFXB4AJX3Za8BVsuOaa-TibNgyv06-gSLQ4zfv3nIKwwP516pra0fDGXVMduU6umqnOpTT75-_IFIHmVtatyCH0T5S1UCJW4HeLM4MDRvt_Q8_eJ12n8GDwSzSet1BT26Q-cHrD_uH8ZBtITZg9FjsRZ7YstC20ACZMpE4iWApsdoICFmF5w4KPZPeYxY_w4TNlTeJKwqZM-X5TbLbtI27TShGSWC3TOZLA4BBl6kGFClUCRbNau8i8nic58oMVOSYEWNR9STKrEKZVEEmEXk4tf3SE3BsbfUKxTW1QNLsUNAuT6thDVY61bpUTuZJhhfOlJY8TxJrS2245r6IyN4o7GpUxIpBPIekinkZkQdTNaxB3FhRjWvX2CbhZSG5hE_c6nVj6gmHiA1CuDwi-YbWbHR1s6Y5-xh4viHUE5mUEXkS9Osfw6-O9t_PwtOd_zERd8klhrc8wqmdPbK7Wq7dPcBeK30_LKw_5AQv7w priority: 102 providerName: Scholars Portal – databaseName: Wiley Online Library Open Access dbid: 24P link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1ba9VAEF5KBfFFvButsqIvCqHJbnaTgC9aLKXYUtRC38LOXmq1SaQ5B1_9Cf5Gf4kzm5zUg0Xw7bA7OWwyl_1mL98w9qKCwgUv8hQk-LSAzKVGmjzVVQ04HVuvbDxtcaj3jov9E3WywV6v7sKM_BDzght5RozX5OAGhu1L0tAvdmipljEF4Gs5TfvE61wczSssRCWuY4lWQfelFSKhmZ9UbF8-vjYjReL-q9Dm34cm_wSzcTbavcVuTjCSvxn1fptt-O4Ou34wbZTfZd9R_fzw_YcjydGEUOutGfrW83gynUpc-YEv-rmPtPPrx0_Mz1HTjrc9fv1VVOSmwxa_QGs5P7M8bq-Py3z4OB--4ryFAJ63ywFHco8d7777tLOXTjUWUouhTqRBlZmrK3AVIFAqVOY1QaTMgVWYqKogPTYGoUOg2n1WKFeaYDNfVboUJsj7bLPrO_-QccqNMFrZItQWYQLUOSB2VKbGOOYg-IS9XH3nxk4E5FQH47wZqZNFQzppok4S9nyW_TbSblwp9ZbUNUsQVXZs6C9Om8nzGsgBauN1mRV0zcyAlmWWOVeDlSBDlbCtlbKbyX-HRmAWR1SKZZ2wZ3M3eh5tp5jO90uSyWRdaanxLx6MtjGPRGKeholbmbByzWrWhrre0519juzemOCpQuuEvYr29Y_Xb_Z3Ph7EX4_-R_gxuyHoDkc8k7PFNhcXS_8EkdUCnkYH-g27uSG1 priority: 102 providerName: Wiley-Blackwell |
| Title | The NLRP3 inflammasome contributes to inflammation‐induced morphological and metabolic alterations in skeletal muscle |
| URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fjcsm.13062 https://www.ncbi.nlm.nih.gov/pubmed/35978267 https://www.proquest.com/docview/2753492679 https://www.proquest.com/docview/2703986368 https://pubmed.ncbi.nlm.nih.gov/PMC9745466 https://doaj.org/article/b1bb9ae67041468ab63700dd9bc3b3f8 |
| Volume | 13 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 2190-6009 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000461650 issn: 2190-5991 databaseCode: KQ8 dateStart: 20100101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 2190-6009 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000461650 issn: 2190-5991 databaseCode: KQ8 dateStart: 20100901 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 2190-6009 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000461650 issn: 2190-5991 databaseCode: DOA dateStart: 20100101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVBFR databaseName: Free Medical Journals customDbUrl: eissn: 2190-6009 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000461650 issn: 2190-5991 databaseCode: DIK dateStart: 20100101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher – providerCode: PRVFQY databaseName: GFMER Free Medical Journals customDbUrl: eissn: 2190-6009 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000461650 issn: 2190-5991 databaseCode: GX1 dateStart: 20100101 isFulltext: true titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php providerName: Geneva Foundation for Medical Education and Research – providerCode: PRVAQN databaseName: PubMed Central customDbUrl: eissn: 2190-6009 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000461650 issn: 2190-5991 databaseCode: RPM dateStart: 20100101 isFulltext: true titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/ providerName: National Library of Medicine – providerCode: PRVPQU databaseName: Health & Medical Collection (Proquest) customDbUrl: eissn: 2190-6009 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000461650 issn: 2190-5991 databaseCode: 7X7 dateStart: 20100901 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: http://www.proquest.com/pqcentral?accountid=15518 eissn: 2190-6009 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000461650 issn: 2190-5991 databaseCode: BENPR dateStart: 20100901 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVFZP databaseName: Scholars Portal Journals: Open Access customDbUrl: eissn: 2190-6009 dateEnd: 20250930 omitProxy: true ssIdentifier: ssj0000461650 issn: 2190-5991 databaseCode: M48 dateStart: 20100901 isFulltext: true titleUrlDefault: http://journals.scholarsportal.info providerName: Scholars Portal – providerCode: PRVAVX databaseName: Springer Open Access Hybrid - NESLI2 2011-2012 customDbUrl: eissn: 2190-6009 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000461650 issn: 2190-5991 databaseCode: 40G dateStart: 20100101 isFulltext: true titleUrlDefault: http://link.springer.com/ providerName: Springer Nature – providerCode: PRVAVX databaseName: SpringerLink Journals (ICM) customDbUrl: eissn: 2190-6009 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000461650 issn: 2190-5991 databaseCode: U2A dateStart: 20100901 isFulltext: true titleUrlDefault: http://www.springerlink.com/journals/ providerName: Springer Nature – providerCode: PRVWIB databaseName: KBPluse Wiley Online Library: Open Access customDbUrl: eissn: 2190-6009 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000461650 issn: 2190-5991 databaseCode: AVUZU dateStart: 20100901 isFulltext: true titleUrlDefault: https://www.kbplus.ac.uk/kbplus7/publicExport/pkg/559 providerName: Wiley-Blackwell – providerCode: PRVWIB databaseName: Wiley Online Library Open Access customDbUrl: eissn: 2190-6009 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000461650 issn: 2190-5991 databaseCode: 24P dateStart: 20100101 isFulltext: true titleUrlDefault: https://authorservices.wiley.com/open-science/open-access/browse-journals.html providerName: Wiley-Blackwell |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELagSIgLKu9AWRnBBaSoiZ_JkVatqopdrQqV9hb5KQpNgsiueu1P4Df2lzB2stGuqODCJVrZ3pXXM575Jh5_g9C7QjPrHclTTbVLmc5sqqjKU1GUGtyxcdzEbIuZODlnpwu-2Cj1FXLCenrgfuH2da51qZyQGQu3hJQWVGaZtaU2VFMfr_mCG9sIpqINZiIXsTwrCXelOaCgkZuU7H8zXR3KIAuy5Y0iaf9tSPPPhMlNIBs90fEuejhASPyxn_ojdMc1j9H96XBI_gRdgejx7NPZnGJQH5B4rbq2djhmpYfyVq7Dy3bsC5K5uf4FsTlI2eK6hZVfW0SsGmhxS9CUywuD49F6_4oPvo677-CzALzjetXBTJ6i8-OjL4cn6VBfITVg5kjqucxsWWhbaABJjGdOBHiUWW04BKncUweNngjvQ90-Q7iVypvMFYWQRHn6DO00beNeIBziIrBUhvnSAETQZa4BN3JVgg2z2rsEvV-vc2UG8vFQA-Oy6mmTSRVkUkWZJOjtOPZHT7lx66iDIK5xRKDJjg2gPNWgPNW_lCdBe2thV8Pe7SoCEVygUZRlgt6M3bDrwlGKaly7CmMyWhaCCviJ571ujDOhEKNB0CYTJLe0Zmuq2z3NxdfI7A3BHWdCJOhD1K-__P3q9PDzNH56-T8W4hV6QMK9jpins4d2lj9X7jWgraWeoLuEzeEpF3KC7h0czeZnk7jZ4DllxW-pmi2q |
| linkProvider | Directory of Open Access Journals |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3NbtQwELZKkYAL4p9AASPgAFLUrJ04yQEhKFTbdneFoJX2lsZ_dEuTlGZXFTcegSfhoXgSZpwfWFH11tvK9kZO5pvxN_Z4hpDniQy1NWzgSy6NH8pA-znPB75IUgnLsTKRctEWEzHcC7en0XSF_OruwmBYZWcTnaHWlcI98nUGvBqT28Xpm-NvPlaNwtPVroRGA4sd8_0UXLb69dZ7kO8LxjY_7G4M_baqgK9AuZlvozjQaSJ1IoEahFFgBJKCQEsVgWsWWW6g0TJhLVarUyzScW5VYJJExCy3HJ57iVwOeRBirv54Gvd7Opi8XLiisAxvaEfAvfqMqGz9UNUFFl8WbGkNdKUCzuK3_4dp_kuf3fq3eYNcb4krfdsg7SZZMeUtcmXcHs3fJqcAODoZffrIKYAWcFbkdVUY6mLhsaiWqem86vsQD79__JyVGrClaVGBvDs7TPMSWswc8Hk0U9Qd6Dcbi_B3Wn-FlRJcBlosapjJHbJ3Id__Llktq9LcJxS9MbCPKrSpAmIi04EEthrlKVhOLa3xyMvuO2eqTXmOlTeOsiZZM8tQJpmTiUee9WOPm0QfZ456h-LqR2BybtdQnXzJWl3P5EDKNDciDkK82JZLweMg0DqViktuE4-sdcLOWotRZ3_x7ZGnfTfoOh7g5KWpFjgm4GkiuIBH3Guw0c-Eg2cIrmLskXgJNUtTXe4pZwcunzi4lFEohEdeOXyd8_rZ9sbnsfv14Px3eEKuDnfHo2y0Ndl5SK4xvDPiYoDWyOr8ZGEeAZOby8dOfSjZv2h9_QM0ZVwl |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELZKkSouiDeBAkbAAaRos3ZiJweEoGXV56oCKu0txC9Y6Cal2VXFjZ_A7-Hn8EuYcR6wouqtt5XtjZzMN-Nv7PEMIU9TFRtn2TBUXNkwVpEJC14MQ5FmCpZjbRPtoy3GYusw3pkkkxXyq7sLg2GVnU30htpUGvfIBwx4NSa3k9nAtWERB5ujV8ffQqwghSetXTmNBiK79vspuG_1y-1NkPUzxkZvP2xshW2FgVCDorPQJTIyWapMqoAmxElkBRKEyCidgJuWOG6h0THhHFau0ywxsnA6smkqJCsch-deIpcljzmGk8mJ7Pd3MJG58AViGd7WToCH9dlR2eCLrmdYiFmwpfXQlw04i-v-H7L5L5X2a-HoGrnaklj6ukHddbJiyxtkbb89pr9JTgF8dLz37oBTADBgblbU1cxSHxePBbZsTedV34fY-P3j57Q0gDNDZxXIvrPJtCihxc4Bq0dTTf3hfrPJCH-n9VdYNcF9oLNFDTO5RQ4v5PvfJqtlVdq7hKJnBrZSxy7TQFJUNlTAXJMiAytqlLMBed5951y36c-xCsdR3iRuZjnKJPcyCciTfuxxk_TjzFFvUFz9CEzU7Ruqk095q_e5GiqVFVbIKMZLboUSXEaRMZnSXHGXBmS9E3beWo86_4v1gDzuu0Hv8TCnKG21wDERz1LBBTziToONfiYcvERwG2VA5BJqlqa63FNOP_vc4uBeJrEQAXnh8XXO6-c7G-_3_a9757_DI7IGmprvbY9375MrDK-P-HCgdbI6P1nYB0Dq5uqh1x5KPl60uv4BelFgYA |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+NLRP3+inflammasome+contributes+to+inflammation%E2%80%90induced+morphological+and+metabolic+alterations+in+skeletal+muscle&rft.jtitle=Journal+of+cachexia%2C+sarcopenia+and+muscle&rft.au=Moritz+Eggelbusch&rft.au=Andi+Shi&rft.au=Bonnie+C.+Broeksma&rft.au=Mariana+V%C3%A1zquez%E2%80%90Cruz&rft.date=2022-12-01&rft.pub=Wiley&rft.issn=2190-5991&rft.eissn=2190-6009&rft.volume=13&rft.issue=6&rft.spage=3048&rft.epage=3061&rft_id=info:doi/10.1002%2Fjcsm.13062&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_b1bb9ae67041468ab63700dd9bc3b3f8 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2190-5991&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2190-5991&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2190-5991&client=summon |